Among Biotechnology, the field of biopharmaceuticals is a core sector in terms of market size and growth potential. Since the market of antibody medical products was launched in 2002 in the world of pharmaceutical products, the biopharmaceutical market rapidly expanded, as the pharmaceutical market worldwide made a historical shift from chemically synthesized medicines to biopharmaceuticals around 2000. Japanese pharmaceutical manufacturers missed the development of antibody medical products, but they are about to rectify the situation by acquiring overseas bio ventures. This presentation provides an overview of the biopharmaceutical market in Japan, highlighting the changes that occurred these past years in the Japanese biopharmaceutical market and the efforts made by Japanese companies in order to take part in this global market.
The webinar is targeted to EU companies seeking to learn about the Japanese Biotechnology Market, and aiming to expand to the Japanese market.
Registration deadline: 18/09/2017
What you will learn during this webinar:
In 40 minutes from your desk, discover how to:
Speaker: Yukio Satoh from Fenetre Partners is a marketing and research manager with over 20 years experience in marketing of automotive companies, and with over 10 years experience in industry consulting and research.
Organiser: EU-Japan Centre for Industrial Cooperation - Brussels Office